Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African Regions

Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African Regions

Two HIV-1 subtype C gp120 protein candidates were the selected antigens for several experimental vaccine regimens now under evaluation in HVTN 100 Phase I/II clinical trial aiming to support the start of the HVTN 702 Phase IIb/III trial in southern Africa, which is designed to confirm and extend the...

Full description

Bibliographic Details
Main Authors: Zihao Wang, Clarisse Lorin, Marguerite Koutsoukos, David Franco, Babak Bayat, Ying Zhang, Andrea Carfi, Susan W. Barnett, Frederick Porter
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Vaccines
Subjects:
vaccine
antigens
gp120
HIV-1
clinical trial
characterization
immunogenicity
Online Access:http://www.mdpi.com/2076-393X/4/2/17

Internet

http://www.mdpi.com/2076-393X/4/2/17

Similar Items